Related Experiment Video
Updated: Jan 16, 2026

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
Analyzing the impact of pharmacogenomics-guided nonsteroidal anti-inflammatory drug alerts in clinical practice
Amanda Massmann1,2, Natasha J Petry1,3, Max Weaver1
1Sanford Imagenetics, Sanford Health, Sioux Falls, SD 57105, United States.
Objectives:
This study evaluates response rates of pharmacogenomics (PGx) nonsteroidal anti-inflammatory drugs (NSAIDs) clinical decision support (CDS) alerts at Sanford Health from May 2020 to December 2024.
Materials And Methods:
A retrospective analysis was conducted on PGx NSAIDs interruptive alerts. Response options were classified into five categories (1) continuation of triggering NSAID order, (2) dose modification, (3) alternative NSAID ordered without PGx implications, (4) alternative analgesic (ie, opioid) ordered, and (5) discontinuation of NSAID without alternative therapy.
Results:
The study analyzed 2361 alert instances from 978 patients. The most common response was discontinuing NSAID without alternative therapy (43%). Dose modifications and orders for alternative analgesics comprised 2.57% and 14.67% of responses, respectively. The initial acceptance rate was 62.6%. Prior NSAID use significantly impacted override rates (60% vs 40%, P < .001). A 409-day breaking point was observed to affect alert acceptance rates, with the highest acceptance in NSAID naïve patients (96.1%).
Discussion:
PGx NSAIDs CDS alert acceptance rates were higher compared to general CDS acceptance rates. This study highlights opportunities for continuous improvement including optimizing alert modality, modifying alert criteria to include look-back periods, and implementing genetically adapted ordersets.
Conclusion:
The initial acceptance rate of PGx NSAIDs CDS alerts was 62.6%, however, with significantly higher acceptance rates in NSAID naïve patients (62.6% vs 96.1%, P < .001). Integration of CDS is vital to the successful implementation of PGx in clinical practice.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Therapeutic Drug Monitoring: Affecting Factors
Dosage Regimen: Individualization
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Pharmacokinetics: Drug–Drug Interactions
Factors Affecting Drug Response: Overview

